155 related articles for article (PubMed ID: 8585063)
21. The treatment of mild to moderate hypertension with ACE inhibitors.
Taylor SH
J Cardiovasc Pharmacol; 1990; 15 Suppl 2():S24-8. PubMed ID: 1691403
[TBL] [Abstract][Full Text] [Related]
22. Quinapril in chronic heart failure.
Northridge DB; Dargie HJ
Am J Hypertens; 1990 Nov; 3(11):283S-287S. PubMed ID: 2261147
[TBL] [Abstract][Full Text] [Related]
23. Haemodynamic response and pharmacokinetics after the first dose of quinapril in patients with congestive heart failure.
Squire IB; Macfadyen RJ; Lees KR; Hillis WS; Reid JL
Br J Clin Pharmacol; 1994 Aug; 38(2):117-23. PubMed ID: 7981011
[TBL] [Abstract][Full Text] [Related]
24. Overview of the clinical development of quinapril.
Frank GJ
Clin Cardiol; 1990 Jun; 13(6 Suppl 7):VII13-8. PubMed ID: 2189616
[TBL] [Abstract][Full Text] [Related]
25. Quinapril: a further update of its pharmacology and therapeutic use in cardiovascular disorders.
Culy CR; Jarvis B
Drugs; 2002; 62(2):339-85. PubMed ID: 11817979
[TBL] [Abstract][Full Text] [Related]
26. Comparative effects of ACE inhibitors and an angiotensin receptor blocker on atherosclerosis and vascular function.
Sun YP; Zhu BQ; Browne AE; Pulukurthy S; Chou TM; Sudhir K; Glantz SA; Deedwania PC; Chatterjee K; Parmley WW
J Cardiovasc Pharmacol Ther; 2001 Apr; 6(2):175-81. PubMed ID: 11509924
[TBL] [Abstract][Full Text] [Related]
27. The treatment of moderate to severe hypertension with ACE inhibitors.
Goldstein RJ
J Cardiovasc Pharmacol; 1990; 15 Suppl 2():S29-35. PubMed ID: 1691404
[TBL] [Abstract][Full Text] [Related]
28. Angiotensin converting enzyme inhibitors and the otolaryngologist.
Cruickshank HE
Clin Otolaryngol Allied Sci; 1995 Jun; 20(3):189-91. PubMed ID: 7554324
[No Abstract] [Full Text] [Related]
29. Comparative pharmacokinetics of captopril, enalapril, and quinapril.
Vertes V; Haynie R
Am J Cardiol; 1992 Apr; 69(10):8C-16C. PubMed ID: 1546641
[TBL] [Abstract][Full Text] [Related]
30. Effects of quinapril on exercise tolerance in patients with mild to moderate heart failure.
Riegger GA
Eur Heart J; 1991 Jun; 12(6):705-11. PubMed ID: 1830551
[TBL] [Abstract][Full Text] [Related]
31. [Angiotensin-converting enzyme, quinapril, in treating chronic cardiac failure].
Gadzhiev AN
Ter Arkh; 2003; 75(1):51-5. PubMed ID: 12652958
[TBL] [Abstract][Full Text] [Related]
32. The effects of ACE inhibitors on exercise capacity in the treatment of congestive heart failure.
Riegger GA
J Cardiovasc Pharmacol; 1990; 15 Suppl 2():S41-6. PubMed ID: 1691406
[TBL] [Abstract][Full Text] [Related]
33. Changes in pulmonary hemodynamics predict benefits in exercise capacity after ACE inhibition in patients with mild to moderate congestive heart failure.
Pelliccia F; Borghi A; Ruggeri A; Cianfrocca C; Morgagni GL; Bugiardini R
Clin Cardiol; 1993 Aug; 16(8):607-12. PubMed ID: 8370193
[TBL] [Abstract][Full Text] [Related]
34. Dose-related effects of ACE inhibition in man: quinapril in patients with moderate congestive heart failure. The Study Group on Neurohormonal Regulation in Congestive Heart Failure: Lausanne, Switzerland; Berlin, Düsseldorf, Munich, Germany.
Nussberger J; Fleck E; Bahrmann H; Delius W; Schultheiss HP; Brunner HR
Eur Heart J; 1994 Dec; 15 Suppl D():113-22. PubMed ID: 7713100
[TBL] [Abstract][Full Text] [Related]
35. Does the duration of action of angiotensin converting enzyme inhibitors affect their safety and adverse effects?
Frank GJ
J Hypertens Suppl; 1989 Sep; 7(5):S17-22. PubMed ID: 2553900
[TBL] [Abstract][Full Text] [Related]
36. Clinical consequences of angiotensin-converting enzyme inhibitor withdrawal in chronic heart failure: a double-blind, placebo-controlled study of quinapril. The Quinapril Heart Failure Trial Investigators.
Pflugfelder PW; Baird MG; Tonkon MJ; DiBianco R; Pitt B
J Am Coll Cardiol; 1993 Nov; 22(6):1557-63. PubMed ID: 8227822
[TBL] [Abstract][Full Text] [Related]
37. The safety and tolerability of quinapril.
Knapp LE; Frank GJ; McLain R; Rieger MM; Posvar E; Singer R
J Cardiovasc Pharmacol; 1990; 15 Suppl 2():S47-55. PubMed ID: 1691407
[TBL] [Abstract][Full Text] [Related]
38. ACE inhibitors in the elderly.
Posvar EL; Sedman AJ
Angiology; 1991 May; 42(5):387-96. PubMed ID: 2035890
[TBL] [Abstract][Full Text] [Related]
39. Effect of angiotensin-converting enzyme inhibitor dosing interval on functional parameters in patients with chronic heart failure.
Krum H; Karrasch J; Hamer A; Hare D; Howes LG; Jackson B; Leslie P
Am Heart J; 1998 Feb; 135(2 Pt 1):237-41. PubMed ID: 9489970
[No Abstract] [Full Text] [Related]
40. Moexipril and quinapril inhibition of tissue angiotensin-converting enzyme activity in the rat: evidence for direct effects in heart, lung and kidney and stimulation of prostacyclin generation.
Torsello A; Locatelli V; Cella SG; Sanguini AM; Berti F
J Endocrinol Invest; 2003 Jan; 26(1):79-83. PubMed ID: 12602539
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
